<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Neurology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E3BD08A4-A316-4022-A884-C8B2B57591CB"><gtr:id>E3BD08A4-A316-4022-A884-C8B2B57591CB</gtr:id><gtr:firstName>Boyd</gtr:firstName><gtr:surname>Ghosh</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700503"><gtr:id>BF8F22AB-2928-459A-B095-0DA4BAC66B4C</gtr:id><gtr:title>Diagnosis and Prognosis in Progressive Supranuclear Palsy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0700503</gtr:grantReference><gtr:abstractText>Progressive supranuclear palsy (PSP) is a disabling, incurable disease, where people have frequent falls and have difficulty moving their eyes. It is however very variable and patients can have many additional problems, such as problems with thinking or speaking.

This variability in the disease can make it difficult to diagnose or to predict how the disease will develop in time. At Cambridge we are combining several methods of research to try to help. 

We are carrying out a range of tests including psychology, measurement of eye movements and monitoring of electromagnetic brain waves early in the disease. As we follow patients through their illness, we will see whether these tests help one to understand the differences between patients? symptoms and importantly whether they can help to predict how the disease will develop.

This would help us to inform patients and their families of the types of problem they are more likely to face in the future. To understand the variation in PSP between different patients would also help us develop better treatments for this disease in the future.</gtr:abstractText><gtr:technicalSummary>Progressive supranuclear palsy (PSP) is a devastating neurodegenerative disease of middle age and older life, which remains essentially untreatable. I will study brain structures and functions that may be used to confirm the diagnosis and associated social cognitive deficits, to predict prognosis and disease type, and be potential surrogate markers for future candidate therapies. 

The objectives are to study patients using a tailored set of neuropsychological tests, measurements of eye movements, and functional brain imaging with Magnetoencephalography (MEG). A secondary objective is to study these patients again at 1 year, to determine the rate of progression of cognitive problems, in relation to baseline characteristics. 

Patients will be recruited from the ?Disorders of Movement and Cognition? clinic which has a large group of patients with PSP. Patients and comparison groups will be studied using psychology tests (memory, organisation, mental flexibility, emotional and social skills). I will then study eye movements because the brain systems eye movement control have alot in common with cognitive brain systems: eye movements may show which patients will develop an earlier dementia. I will study brain function and connectivity in brain networks using MEG. I predict that connectivity is impaired early in the disease before brain shrinkage (atrophy) is significant, and that this could be a sensitive measure of potential new treatments. 

Some of our patients will die from their disease during the 3 years (typically 2-4/year). Many patients have declared their intention to donate to the Cambridge Brain Bank. This pathology information will be used to reinforce the findings from the main research methods. 

Our research has specific aims to improve the assessment, care and treatment of patients with PSP. However, PSP is an archetype of diseases that give problems with both mental functions and movement. There is therefore a broader potential medical andentific benefit regarding Parkinson?s disease and dementias which are also actively researched in my department.</gtr:technicalSummary><gtr:fund><gtr:end>2010-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>199963</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Cognition and Brain Sciences Unit</gtr:department><gtr:description>CBSU collaboration</gtr:description><gtr:id>9A4C9052-56EE-4F23-A226-F40F83C3DE7D</gtr:id><gtr:impact>This is a multidisciplinary collaboration involving psychologists, computer scientists and clinicians. Publications of papers are ongoing but include Brain as detailed.</gtr:impact><gtr:outcomeId>MLoF2VDYBXi-1</gtr:outcomeId><gtr:partnerContribution>Research experience in emotion recognition and theory of mind enabling broad based research within the field, amongst a novel patient population.</gtr:partnerContribution><gtr:piContribution>Our team recruited a patient population to investigate the presence of emotion recognition and theory of mind deficits.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Lecture for PD masterclass</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CA894543-49B3-4AC4-86C2-ADFF77159117</gtr:id><gtr:impact>British Geriatric society hold a Parkinson's disease masterclass which I was invited to speak at. My role initially was to disseminate the care pathway to PD professionals but later evolved into teaching about PSP and other Parkinson's plus conditions.

Continuing interest in care pathway for PSP association.</gtr:impact><gtr:outcomeId>cRpWd5yQMTD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advisory panel on care pathway</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>09127D16-ADBF-4589-B35B-3EFF63BB1765</gtr:id><gtr:impact>Care pathway was published nationally with local events to roll out to publicise it amongst PD nurses and other health professionals.

Generated some media interest.</gtr:impact><gtr:outcomeId>LcDyRQZTQ12</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PSP association symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>309E9536-67F3-4A73-ADC6-21D638777FDE</gtr:id><gtr:impact>Carers for patients with progressive supranuclear palsy and health care professionals attended a symposium organised by the PSP association. I talked about the cognitive and behavioural aspects of the disease which led to extended discussion during and after the presentation.

Health care paractitioners asked to be included in a PSP network.</gtr:impact><gtr:outcomeId>BCUHLnLCvDW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1250</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sackler Fellowship</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Raymond and Beverly Sackler Foundation</gtr:fundingOrg><gtr:id>24884131-DD25-418D-A47A-6BA0F9519A70</gtr:id><gtr:outcomeId>CGLwF5crHvb2</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sackler Fellowship</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Raymond and Beverly Sackler Foundation</gtr:fundingOrg><gtr:id>61EC9E62-FE5E-4B38-8CFD-4B89EDE3AD13</gtr:id><gtr:outcomeId>CGLwF5crHvb0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1250</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sackler Fellowship</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Raymond and Beverly Sackler Foundation</gtr:fundingOrg><gtr:id>FD3C56EC-22A7-433D-A168-8582EA1CABAF</gtr:id><gtr:outcomeId>CGLwF5crHvb1</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of PSP association advisory panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>86012246-33CB-43ED-8A99-F9469F1A67B8</gtr:id><gtr:outcomeId>LneXhKjmgus</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Database of patients with movement disorders such as progressive supranuclear palsy with collection of biological materials for analysis.</gtr:description><gtr:id>BDFA4B62-EBC2-43A2-98C6-AE9D7575023D</gtr:id><gtr:impact>Articles to be submitted.</gtr:impact><gtr:outcomeId>sdisyBTCtpf</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HSB</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2F6F59AF-12B4-40AF-ADBC-34BB2712716E</gtr:id><gtr:title>Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5f0442ffcdcd359cb84f7e73b5cdf13"><gtr:id>a5f0442ffcdcd359cb84f7e73b5cdf13</gtr:id><gtr:otherNames>Rittman T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>585d34ecb38574.80844156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7831FE1-29F5-44D4-81CF-8DBD72F4F6EA</gtr:id><gtr:title>Emotion recognition in progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe729939bb9d5f88e3d5c0f5bfee3634"><gtr:id>fe729939bb9d5f88e3d5c0f5bfee3634</gtr:id><gtr:otherNames>Ghosh BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>F0CEE28FDE7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B3C216C-F90F-474B-983F-9A6DCD0159C5</gtr:id><gtr:title>The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5f0442ffcdcd359cb84f7e73b5cdf13"><gtr:id>a5f0442ffcdcd359cb84f7e73b5cdf13</gtr:id><gtr:otherNames>Rittman T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_16613_23_23303961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59BB671D-1316-4CCF-921F-1C118E1C7D14</gtr:id><gtr:title>When is 'idiopathic intracranial hypertension' no longer idiopathic?</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00431b89459b3c0076263b28090ae942"><gtr:id>00431b89459b3c0076263b28090ae942</gtr:id><gtr:otherNames>Suetterlin K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>58c575101c01f7.83511836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35637B67-0DA7-4678-BFD3-5D01CF69C0A3</gtr:id><gtr:title>Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>NeuroImage. Clinical</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1bc8d196cb56b949d8dc7d8da57d12d"><gtr:id>e1bc8d196cb56b949d8dc7d8da57d12d</gtr:id><gtr:otherNames>Hughes LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2213-1582</gtr:issn><gtr:outcomeId>pm_16613_23_23853762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F762C29-09C3-4DC2-BA57-DC80651062A9</gtr:id><gtr:title>Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d490fac5814ae4fc2fc861fb24945ed0"><gtr:id>d490fac5814ae4fc2fc861fb24945ed0</gtr:id><gtr:otherNames>Perneczky R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>D99EAF16_8D99EAF16_8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A330491F-4F2F-4F19-AAA0-253693243E4F</gtr:id><gtr:title>Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f437eec31938ee27ab7bd676741353d"><gtr:id>9f437eec31938ee27ab7bd676741353d</gtr:id><gtr:otherNames>Rowe JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>0E31411B3D8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36FB4984-4379-4100-BD48-E626F8F31822</gtr:id><gtr:title>A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe729939bb9d5f88e3d5c0f5bfee3634"><gtr:id>fe729939bb9d5f88e3d5c0f5bfee3634</gtr:id><gtr:otherNames>Ghosh BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16613_23_24058574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5CCE2F8-B062-4F52-9112-3E8D7C2AE8AB</gtr:id><gtr:title>Social cognitive deficits and their neural correlates in progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe729939bb9d5f88e3d5c0f5bfee3634"><gtr:id>fe729939bb9d5f88e3d5c0f5bfee3634</gtr:id><gtr:otherNames>Ghosh BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_16613_23_22637582</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>230F58E6-AB8F-40B5-A0F9-30594A29F24B</gtr:id><gtr:title>The binaural masking level difference: cortical correlates persist despite severe brain stem atrophy in progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Journal of neurophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1bc8d196cb56b949d8dc7d8da57d12d"><gtr:id>e1bc8d196cb56b949d8dc7d8da57d12d</gtr:id><gtr:otherNames>Hughes LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3077</gtr:issn><gtr:outcomeId>doi_55f9849845ef31a4</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700503</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>